WELCOME TO The PHARMACEUTICAL REPORT
Home > News >
Trending news >
Awaiting FDA nod, Novartis touts latest data on gene therapy Zolgensma
fiercepharma | May 06, 2019
Welcome to Pharmaprojects’ 2023 review of trends in pharmaceutical R&D. For over 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’llexamine the state of play at the start of 2023.
Dom Nicastro | April 03, 2020
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE